Proposed Data Collections Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[INFO-97-10]

Proposed Data Collections Submitted for Public Comment and

Recommendations

In compliance with the requirement of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995 for opportunity for public comment on

proposed data collection projects, the Centers for Disease Control and

Prevention (CDC) will publish periodic summaries of proposed projects.

To request more information on the proposed projects or to obtain a

copy of the data collection plans and instruments, call the CDC Reports

Clearance Officer on (404) 639-7090.

Comments are invited on: (a) Whether the proposed collection of

information

[[Page 22951]]

is necessary for the proper performance of the functions of the agency,

including whether the information shall have practical utility; (b) the

accuracy of the agency's estimate of the burden of the proposed

collection of information; (c) ways to enhance the quality, utility,

and clarity of the information to be collected; and (d) ways to

minimize the burden of the collection of information on respondents,

including through the use of automated collection techniques for other

forms of information technology. Send comments to Wilma Johnson, CDC

Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA

30333. Written comments should be received within 60 days of this

notice.

Proposed Projects

1. A Survey to Assess The Knowledge, Attitudes And Practices of

Health Care Providers Serving Pregnant Women Regarding HIV Counseling

and Testing and the Use Of Zidovudine (ZDV) During Pregnancy--New--This

is a new data collection. The purpose of this survey is to assess the

knowledge, attitudes, and practices of health care providers serving

pregnant women regarding HIV counseling and testing and use of ZDV

during pregnancy. Data will be collected and reported to CDC to

describe: (1) Providers' current practices in providing prenatal care

to HIV-infected women, offering HIV counseling and testing to pregnant

women, and offering ZDV to HIV-infected pregnant women; (2) providers'

knowledge of the ACTG 076 results and PHS perinatal transmission

guidelines; (3) providers' attitudes regarding HIV counseling and

testing of pregnant women; and, (4) providers' knowledge and experience

in the use of ZDV in treating HIV-infected pregnant women.

The intended population to be studied is physicians and nurse-

midwives providing prenatal care in four areas (State of Connecticut,

potential population approximately 685; State of North Carolina,

potential population approximately 1,500; Dade County, FL, potential

population approximately 500; Brooklyn, NY, potential population

approximately 260) where institutions are currently conducting a CDC-

funded study related to implementation of the PHS guidelines to prevent

perinatal transmission of HIV. The total estimated cost to respondents

is $40,370.

----------------------------------------------------------------------------------------------------------------

Number of

Number of responses/ Total burden

Respondents respondents respondent (in hrs.)

(in hrs.)

----------------------------------------------------------------------------------------------------------------

Census: Secretaries............................................ 2,800 1 46

Census: Midwives............................................... 350 1 6

Pilot: Midwives................................................ 15 1 2.5

Pilot: Doctors................................................. 240 1 40

Survey: Midwives............................................... 350 1 58.3

Survey: Doctors................................................ 2,000 1 333.3

------------------------------------------------

Total...................................................... .............. .............. 486.1

----------------------------------------------------------------------------------------------------------------

Dated: April 22, 1997.

Wilma G. Johnson,

Acting Associate Director for Policy Planning and Evaluation, Centers

for Disease Control and Prevention (CDC).

[FR Doc. 97-10826 Filed 4-25-97; 8:45 am]

BILLING CODE 4163-18-P